| Business Name: |
Clinica Venamer LLC |
| Contact Person: |
Mauro Belmonte |
| Address: |
10200 Nw 25th St # 114, Miami, Florida 33172 |
| Phone Number: |
(305) 594-6505 |
| Annual Revenue (USD): |
$500.000 to $999.999 |
| Founding Year: |
2010 |
| Location Type: |
Single Location |
| Employee Number: |
1 to 4 |
| Business Type: |
B2C (Business to Consumer) |
| Business Category: |
Doctors |
| SIC Code: |
8011 |
| NAICS Code: |
621111 |
| Share This Business: |
|
| Related Businesses: |
Michael W Formisano Md - Miami, FL 33172
Family Medical Center - Miami, FL 33172
Enrique Ruedapa Pa - Miami, FL 33172
Drs Support Med Inc - Miami, FL 33172
Hernandez Aleida M MD - Miami, FL 33172
Pila-Collazo Lourdes MD - Miami, FL 33172
Express Radiology - Miami, FL 33172
Ravelo Raul MD - Miami, FL 33172
Reyes Ciro R MD - Miami, FL 33172
Garcia-Piedra Orlando MD - Miami, FL 33172
England James J MD - Miami, FL 33172
Tercilla Oscar F MD - Miami, FL 33172
Md's Billing & Collections Inc - Miami, FL 33172
J M Dental Group Inc - Miami, FL 33172
Sara N Llerena Md - Miami, FL 33172
Huang David MD - Miami, FL 33172
Ubeda-Aguilar Tenet Physician Services Dr - Miami, FL 33172
Kendall Therapeutics Inc - Miami, FL 33172
Quintana Giraldo M OD - Miami, FL 33172
Westchester Medical Center Inc - Miami, FL 33172
|
The company Clinica Venamer LLC provides B2C services in the form of Doctors from its single location in Florida.
1 to 4 employees work for Clinica Venamer LLC, and the business now earns $500.000 to $999.999 per annum.
Clinica Venamer LLC was launched in 2010 and is classified under SIC code and category 8011 , and NAICS number and grouping 621111 .
To contact Clinica Venamer LLC, please call Mauro Belmonte with the phone number (305) 594-6505 or visit its single location at 10200 Nw 25th St # 114 in Miami, Florida 33172.
The location of the single location can also be found using the coordinates 25.796693,-80.361909.
Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.